Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes

Nature Medicine

Volumn 4, Issue 2, 1998, Pages 181-186

  Donahue, Robert E ^a   Bunnell, Bruch A ^b,d   Zink, M Christine ^c   Metzger, Mark E ^a   Westro, Robert P ^a   Kirby, Martha R ^a   Unangst, Tami ^c   Clements, Janice E ^c   Morgan, Richard A ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFER; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LYMPH NODES; MACACA MULATTA; OLIGONUCLEOTIDES, ANTISENSE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0031905617     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0298-181     Document Type: Article

References (22)

1. Baltimore, D. Intracellular immunization. Nature 335, 395-397 (1988).
2. Vanden Driessche T., Chuah, M.K.L., Chang, H.-K., Ensoli, B. & Morgan, R.A. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4 T lymphocytes by retroviral vectors expressing anti-HIV genes. J. Virol. 69, 40-45 (1995).
3. Trono, D., Feinberg, M.B. & Baltimore, D. HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59, 113-120 (1989).
4. Woffendin, C., Rangs, U., Yang, Z.-Y., Xu, L. & Nabel, G.J. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. USA 93, 2889-2894 (1996).
5. Morgan, R.A. & Walker, R. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein to syngeneic lymphocytes in HIV-1 infected identical twins. Hum. Gene Ther. 7, 1281-1306 (1996).
6. Ensoli, B., Barillari, G., Salahuddin, S.Z., Gallo, R.C. & Wong-Stall, F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 344, 84-86 (1990).
7. Banda, N.K. et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp Med. 176, 1099-1106 (1992).
8. Gardner, M.B., Endres, M. & Barry, P. The simian retroviruses: SIV and SRV. in The Retroviridae. The Viruses, Vol. 3 (ed. Levy, J.A.) 133-276 (Plenum Press, New York, 1994).
9. Kindt, T.J., Hirsch, V.M., Johnson, P.R. & Sawasdikosol, S. Animal models for acquired immunodeficiency syndrome. Adv. Immunol. 52, 425-474 (1992).
10. Bunnell, B.A., Metzger, M., Byrne, E., Morgan, R.A. & Donahue, R.E. Efficient in vivo marking of primary CD4 T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 89, 1987-1995 (1997).
11. Endres, C.L., Bergquam, E.P., Axthelm, M.K. & Wong, S.W. Suppression of simian immunodeficiency virus replication by human immunodeficiency virus type 1 trans-dominant negative rev mutants. J. Virol. 69, 5164-516 (1995).
12. Bunnell, B.A., Muul, L.M., Donahue, R.E., Blaese, R.M. & Morgan, R.A. High-efficiency retroviral mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7739-7743 (1995).
13. Siekevitz, M. et al. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science 238, 1575-1578 (1992).
14. Levine, B.L. et al. Antiviral effect and ex vivo CD4 T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272, 1939-1943 (1996).
15. Lohman, B.L. et al. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68, 7021-7029 (1994).
16. Kestler, H.W. et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662 (1991).
17. Haigwood, H.L. et al. Passive immune globulin therapy in the SIV/macaque model: Early intervention of immunodeficiency and immunosuppression. Immunol. Lett. 51, 107-114 (1996).
18. Pantaleo, G. How immune-based interventions can change HIV therapy. Nature Med. 3, 483-486 (1997).
19. + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Biood 87, 1644-1653 (1996).
20. Clements, J.E. et al. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69, 2737-2744 (1995).
21. Mankowski, J.L. et al. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J. Virol. 68, 8202-8208 (1994).
22. Laird, N.M. & Ware, J.H. Random-effects models for longitudinal data. Biometrics 38, 963-974 (1982).